Overview: the maturing of proteomics in cardiovascular research.
about
Posttranslational control of HuR functionCardiovascular proteomics in the era of big data: experimental and computational advancesProteomic analysis in cardiovascular researchPost-translational modifications induce significant yet not extreme changes to protein structure.Reproducible ion-current-based approach for 24-plex comparison of the tissue proteomes of hibernating versus normal myocardium in swine modelsDifferential protein expression and basal lamina remodeling in human heart failureCharacterization of efficient proteolysis by trypsin loaded macroporous silica.Post-translational modifications of exosomal proteins.Quantitative proteomics in cardiovascular research: global and targeted strategiesAnalytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion modelPseudo-acetylation of K326 and K328 of actin disrupts Drosophila melanogaster indirect flight muscle structure and performanceAn integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in ChinaAberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.Systems proteomics for translational network medicine.Secreted proteins as a fundamental source for biomarker discovery.Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophyTop-down proteomics of a drop of blood for diabetes monitoring.Application of proteomics in the mechanistic study of traditional Chinese medicine.Proteomics in hypertension and other cardiovascular diseases.Recent advances in proteomic technologies applied to cardiovascular disease.Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis.Current trends in magnetic particle enrichment for mass spectrometry-based analysis of cardiovascular protein biomarkers.Proteomics of cell-cell interactions in health and disease.Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.Phosphorylation of Serine422 increases the stability and transactivation activities of human Osterix.Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins.Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury.Prediction of carbamylated lysine sites based on the one-class k-nearest neighbor method.How are you feeling today? Quality of life after aortic surgery.Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.
P2860
Q26745825-AD938C40-5260-48CF-888C-31239FC7C16EQ28074789-D2673B52-4481-4011-9A5E-35072EE417D7Q28087536-DA7F90B2-D8C1-400B-B81D-1BC092845749Q30420946-DB7CEB82-A4FA-45C5-B1EB-5462CC9957D7Q33588975-331ECC20-4227-4EC0-90A9-E41D3D0DD9FEQ33925177-B5375312-C23A-4229-819A-5663224BC02DQ33976576-84EC77E7-2C99-4825-97A0-1E6A9FE6272EQ34041809-39EC389F-6DD9-4C90-8554-BC12C2E2C309Q34156082-FBC09861-D38C-430B-AED7-6EE5F3EBA816Q34604043-F2D12AA0-1378-4B17-8420-308DE40C40E5Q34982162-006D0367-8EC3-4112-BD5F-2637C13B7008Q35545773-2C640D57-8B92-4EC4-A029-B7E8FAE647E4Q35621303-603889D8-D224-4BE9-89EF-D428BB858F53Q36046973-69DEB3B0-5E2D-455A-8B52-E8239633E4E4Q36303108-45921D55-5923-416F-AA1B-B645D518AA9DQ36452973-EAD6ED61-3073-4220-BB73-6610DDF5BDDCQ37142875-7CD72B7F-1941-43B0-97CE-DCA08435C919Q37289370-209FDD9C-EF0A-4251-A51E-383714348F51Q37714134-9386A52E-F1BE-45B8-BA68-E0A8658CD88BQ37936522-4E8D17BA-BA2E-48B6-9C6F-5E61730B7019Q38020003-70379B30-89B9-45CA-B51D-DACAC9394D12Q38034137-3F60B6EA-FE46-460B-94AA-E5D64EEF8A44Q38106664-2E2925D1-00FE-4AA4-8FB8-0EAB2B42F5FCQ38364469-C8AEBEB0-B3A9-4797-AF91-57FB738E6C99Q38629150-18C80AFA-98CF-4FD9-875D-76075FB298F3Q38780174-635B8540-6E45-4097-9D8A-35ED973BA4ADQ38904919-CBBDAA40-39F7-4CC9-89DB-603E1E39B9DDQ38961899-853D4469-1C0B-4BB6-876A-1D3D949406B0Q39185614-3BDE5D64-2707-4CA9-B417-3484F7FEDD0CQ42139860-863EB264-5EEC-4478-B3AE-08E66598985CQ44845081-9F2BC5EE-C24F-4DDE-953B-3D5180470F74Q47708175-05CE1B25-E8B2-4D54-9F56-C51EA9FB9CE8Q48658510-CA8696AF-7D5C-4BE4-BFA6-47C22AEED981
P2860
Overview: the maturing of proteomics in cardiovascular research.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Overview: the maturing of proteomics in cardiovascular research.
@ast
Overview: the maturing of proteomics in cardiovascular research.
@en
type
label
Overview: the maturing of proteomics in cardiovascular research.
@ast
Overview: the maturing of proteomics in cardiovascular research.
@en
prefLabel
Overview: the maturing of proteomics in cardiovascular research.
@ast
Overview: the maturing of proteomics in cardiovascular research.
@en
P2860
P1433
P1476
Overview: the maturing of proteomics in cardiovascular research.
@en
P2093
Jennifer E Van Eyk
P2860
P304
P356
10.1161/CIRCRESAHA.110.226894
P577
2011-02-01T00:00:00Z